These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
305 related articles for article (PubMed ID: 18174613)
1. Stenting of vertebral artery origin atherosclerosis in high-risk patients: bare or coated? A single-center consecutive case series. Akins PT; Kerber CW; Pakbaz RS J Invasive Cardiol; 2008 Jan; 20(1):14-20. PubMed ID: 18174613 [TBL] [Abstract][Full Text] [Related]
2. Drug-eluting stent for the treatment of symptomatic vertebral origin stenosis: Long-term results. Chen X; Huang Q; Hong B; Zhang Y; Xu Y; Liu J J Clin Neurosci; 2011 Jan; 18(1):47-51. PubMed ID: 20888236 [TBL] [Abstract][Full Text] [Related]
3. Percutaneous vertebral artery intervention: a necessary tool in every interventional cardiologist armamentarium. Zavala-Alarcon E; Emmans L; Cecena F; Little R; Bant A Cardiovasc Revasc Med; 2007; 8(2):107-13. PubMed ID: 17574170 [TBL] [Abstract][Full Text] [Related]
4. Symptomatic ostial vertebral artery stenosis treated with tubular coronary stents: clinical results and restenosis analysis. Lin YH; Juang JM; Jeng JS; Yip PK; Kao HL J Endovasc Ther; 2004 Dec; 11(6):719-26. PubMed ID: 15615563 [TBL] [Abstract][Full Text] [Related]
5. Percutaneous intervention for posterior fossa ischemia. A single center experience and review of the literature. Zavala-Alarcon E; Emmans L; Little R; Bant A Int J Cardiol; 2008 Jun; 127(1):70-7. PubMed ID: 17651834 [TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes and influencing factors of in-stent restenosis after stenting for symptomatic stenosis of the vertebral V1 segment. Che WQ; Dong H; Jiang XJ; Peng M; Zou YB; Xiong HL; Yang YJ; Gao RL J Vasc Surg; 2018 Nov; 68(5):1406-1413. PubMed ID: 29789215 [TBL] [Abstract][Full Text] [Related]
7. Vertebral artery origin angioplasty and primary stenting: safety and restenosis rates in a prospective series. Cloud GC; Crawley F; Clifton A; McCabe DJ; Brown MM; Markus HS J Neurol Neurosurg Psychiatry; 2003 May; 74(5):586-90. PubMed ID: 12700299 [TBL] [Abstract][Full Text] [Related]
8. Angioplasty and stenting of symptomatic and asymptomatic vertebral artery stenosis: to treat or not to treat. Parkhutik V; Lago A; Tembl JI; Aparici F; Vazquez V; Mainar E Eur J Neurol; 2010 Feb; 17(2):267-72. PubMed ID: 19765054 [TBL] [Abstract][Full Text] [Related]
9. Experience with vertebral artery origin stenting and ostium dilatation: results of treatment and clinical outcomes. Rangel-Castilla L; Gandhi S; Munich SA; Cress MC; Sonig A; Krishna C; Hopkins LN; Snyder KV; Levy EI; Siddiqui AH J Neurointerv Surg; 2016 May; 8(5):476-80. PubMed ID: 25838198 [TBL] [Abstract][Full Text] [Related]
10. Restenosis rates following vertebral artery origin stenting: does stent type make a difference? Ogilvy CS; Yang X; Natarajan SK; Hauck EF; Sun L; Lewis-Mason L; Hopkins LN; Siddiqui AH; Levy EI J Invasive Cardiol; 2010 Mar; 22(3):119-24. PubMed ID: 20197579 [TBL] [Abstract][Full Text] [Related]
11. Arterial occlusions increase the risk of in-stent restenosis after vertebral artery ostium stenting. Li J; Hua Y; Needleman L; Forsberg F; Eisenbray JR; Li Z; Liu R; Tian X; Jiao L; Liu JB J Neurointerv Surg; 2019 Jun; 11(6):574-578. PubMed ID: 30337379 [TBL] [Abstract][Full Text] [Related]
12. Endovascular treatment of supra-aortic extracranial stenoses in patients with vertebrobasilar insufficiency symptoms. Zaytsev AY; Stoyda AY; Smirnov VE; Scherbyuk AN; Kondrashin SA; Artukchina EG; Kikevitch VA Cardiovasc Intervent Radiol; 2006; 29(5):731-8. PubMed ID: 16718428 [TBL] [Abstract][Full Text] [Related]
13. Symptomatic intracranial vertebral artery atherosclerotic stenosis (≥70%) with concurrent contralateral vertebral atherosclerotic diseases in 88 patients treated with the intracranial stenting. Wang ZL; Gao BL; Li TX; Cai DY; Zhu LF; Bai WX; Xue JY; Li ZS Eur J Radiol; 2015 Sep; 84(9):1801-4. PubMed ID: 26119803 [TBL] [Abstract][Full Text] [Related]
14. Long-Term Risk of In-Stent Restenosis and Stent Fracture for Extracranial Vertebral Artery Stenting. Li MKA; Tsang ACO; Tsang FCP; Ho WS; Lee R; Leung GKK; Lui WM Clin Neuroradiol; 2019 Dec; 29(4):701-706. PubMed ID: 30039353 [TBL] [Abstract][Full Text] [Related]
15. Outcomes of endovascular treatments for in-stent restenosis in patients with mesenteric atherosclerotic disease. Zhou Y; Ryer EJ; Garvin RP; Pham A; Irvan JL; Orlova K; Elmore JR J Vasc Surg; 2019 Mar; 69(3):833-842. PubMed ID: 30528413 [TBL] [Abstract][Full Text] [Related]
16. Stenting of symptomatic vertebral artery ostium stenosis with self-expanding stents. Li Z; Zhang Y; Hong B; Deng B; Xu Y; Zhao W; Liu J; Huang Q J Clin Neurosci; 2014 Feb; 21(2):274-7. PubMed ID: 24128770 [TBL] [Abstract][Full Text] [Related]
18. Stenting of vertebrobasilar arteries in symptomatic atherosclerotic disease and acute occlusion: case series and review of the literature. Eberhardt O; Naegele T; Raygrotzki S; Weller M; Ernemann U J Vasc Surg; 2006 Jun; 43(6):1145-54. PubMed ID: 16765230 [TBL] [Abstract][Full Text] [Related]
19. Stent fracture and restenosis after placement of a drug-eluting device in the vertebral artery origin and treatment with the stent-in-stent technique. Report of two cases. Kim SR; Baik MW; Yoo SH; Park IS; Kim SD; Kim MC J Neurosurg; 2007 May; 106(5):907-11. PubMed ID: 17542539 [TBL] [Abstract][Full Text] [Related]
20. [Endovascular treatment of vertebral artery origin stenosis in high risk patients]. Kizilkiliç O; Oğuzkurt L; Yildirim T; Tercan F; Karakurum B; Karaca S; Giray S; Arlier Z Tani Girisim Radyol; 2004 Sep; 10(3):252-8. PubMed ID: 15470631 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]